{
    "SPADE_UN_25692": {
        "Sequence Information": {
            "Peptide Name": "GV30 (1-23)",
            "Sequence": "GVIFNALKGVAKTVAAQLLKKAR",
            "Sequence Length": 23,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anti-Mammalian Cell",
                "Antibiofilm"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "Generation of truncated derivatives through in silico enzymatic digest of peptide GV30 target MRSA both in vitro and in vivo.",
                    "Pubmed ID": "34584638",
                    "Reference": "Comput Struct Biotechnol J. 2021;19:4984-4996",
                    "Author": "Ma Y, Yao A, Chen X, Wang L, Ma C, Xi X, Chen T, Shaw C, Zhou M",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/34584638"
                }
            ],
            "Mass": 2396.92,
            "PI": 11.33,
            "Net Charge": 5,
            "Hydrophobicity": 0.51,
            "Frequent Amino Acids": "AKL",
            "Absent Amino Acids": "CDEHMOPSUWY",
            "Basic Residues": 5,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 13,
            "Polar Residues": 10,
            "Positive Residues": 5,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_UN_25692",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_15270",
                    "Similarity": 1.0,
                    "Sequence": "GVIFNALKGVAKTVAAQLLKKARCKLDKSC"
                },
                {
                    "SPADE_ID": "SPADE_UN_25693",
                    "Similarity": 1.0,
                    "Sequence": "GVIFNALKGVAKTVAAQLLKK"
                },
                {
                    "SPADE_ID": "SPADE_UN_25694",
                    "Similarity": 1.0,
                    "Sequence": "GVIFNALKGVAKTVAAQLLK"
                }
            ],
            "Hemolytic Activity": "Horse erythrocytes:17.55% Hemolysis=32 µM,Horse erythrocytes:10% Hemolysis=16.148 µM,Horse erythrocytes:50% Hemolysis=115.29 µM,Human keratinocytes HaCat:<5% Cytotoxicity=10 µM,Human keratinocytes HaCat:28% Cytotoxicity=100 µM",
            "Target Organism": "Staphylococcus aureus NCTC 10788(MIC=2µM),Staphylococcus aureus NCTC 10788(MBC=16µM),Escherichia coli ATCC 8739(MIC=4µM),Escherichia coli ATCC 8739(MBC=8µM),Staphylococcus aureus NCTC 12493(MIC=2µM),Staphylococcus aureus NCTC 12493(MBC=2µM),Klebsiella pneumoniae ATCC 43816(MIC=32µM),Klebsiella pneumoniae ATCC 43816(MBC=64µM),Enterococcus faecium NTCC 12697(MIC=16µM),Enterococcus faecium NTCC 12697(MBC=16µM),Pseudomonas aeruginosa ATCC 9027(MIC=16µM),Pseudomonas aeruginosa ATCC 9027(MBC=16µM),Staphylococcus aureus MR(MIC=2-8µM),Staphylococcus aureus MR(MBC=8µM),Staphylococcus aureus ATCC BAA-1707(MIC=8µM),Staphylococcus aureus ATCC BAA-1707(MBC=8µM),Staphylococcus aureus NCTC 12493(MIC=4µM)"
        }
    }
}